Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$0.65 - $1.25 $821 - $1,580
-1,264 Reduced 7.07%
16,621 $14,000
Q3 2023

Oct 23, 2023

SELL
$0.87 - $1.13 $228 - $297
-263 Reduced 1.45%
17,885 $16,000
Q1 2023

May 11, 2023

SELL
$0.8 - $1.74 $80 - $174
-100 Reduced 0.55%
18,148 $15,000
Q4 2022

Feb 07, 2023

SELL
$1.09 - $20.4 $436 - $8,159
-400 Reduced 2.15%
18,248 $23,000
Q3 2022

Nov 14, 2022

SELL
$1.7 - $20.52 $12,071 - $145,712
-7,101 Reduced 27.58%
18,648 $30,000
Q2 2022

Jul 19, 2022

BUY
$1.35 - $2.29 $8,100 - $13,740
6,000 Added 30.38%
25,749 $54,000
Q1 2022

May 04, 2022

SELL
$1.46 - $2.45 $292 - $490
-200 Reduced 1.0%
19,749 $40,000
Q4 2021

Jan 31, 2022

SELL
$2.13 - $3.46 $745 - $1,211
-350 Reduced 1.72%
19,949 $46,000
Q3 2021

Oct 29, 2021

BUY
$3.14 - $3.9 $3,140 - $3,900
1,000 Added 5.18%
20,299 $70,000
Q1 2021

May 04, 2021

BUY
$4.33 - $6.63 $23,763 - $36,385
5,488 Added 39.74%
19,299 $88,000
Q4 2020

Feb 11, 2021

BUY
$4.87 - $17.29 $467 - $1,659
96 Added 0.7%
13,811 $83,000
Q3 2020

Nov 05, 2020

BUY
$15.08 - $27.04 $36,418 - $65,301
2,415 Added 21.37%
13,715 $225,000
Q2 2020

Aug 12, 2020

BUY
$14.57 - $23.96 $14,803 - $24,343
1,016 Added 9.88%
11,300 $263,000
Q1 2020

May 11, 2020

BUY
$10.27 - $21.23 $105,616 - $218,329
10,284 New
10,284 $152,000
Q4 2018

Feb 11, 2019

SELL
$19.05 - $36.45 $181,870 - $347,988
-9,547 Closed
0 $0
Q3 2018

Nov 06, 2018

SELL
$34.41 - $44.23 $32,689 - $42,018
-950 Reduced 9.05%
9,547 $354,000
Q2 2018

Jul 31, 2018

BUY
$39.21 - $50.29 $53,521 - $68,645
1,365 Added 14.95%
10,497 $412,000
Q1 2018

May 14, 2018

SELL
$41.7 - $64.16 $1,918 - $2,951
-46 Reduced 0.5%
9,132 $448,000
Q4 2017

Feb 12, 2018

BUY
$28.58 - $49.91 $262,307 - $458,073
9,178
9,178 $415,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $765M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.